Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CHUGAI-PHARMACEUTICAL-CO--6491165/news/Chugai-Pharmaceutical-Presents-Results-from-Phase-III-Study-of-Satralizumab-in-NMOSD-at-ECTRIMS-20-27422086/?utm_source=whatsapp&utm_medium=social&utm_campaign=share